Onconetix, Inc. Quarterly Operating Income (Loss) in USD from Q1 2021 to Q2 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Onconetix, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2021 to Q2 2025.
- Onconetix, Inc. Operating Income (Loss) for the quarter ending June 30, 2025 was -$1.94M, a 85.8% increase year-over-year.
- Onconetix, Inc. Operating Income (Loss) for the twelve months ending June 30, 2025 was -$46.3M, a 9.63% increase year-over-year.
- Onconetix, Inc. annual Operating Income (Loss) for 2024 was -$56.5M, a 56.8% decline from 2023.
- Onconetix, Inc. annual Operating Income (Loss) for 2023 was -$36M, a 167% decline from 2022.
- Onconetix, Inc. annual Operating Income (Loss) for 2022 was -$13.5M, a 294% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)